Penile Cancer Market Report 2026

Penile Cancer Market Overview

• Penile Cancer market size has reached to $25.86 billion in 2025 • Expected to grow to $37.41 billion in 2030 at a compound annual growth rate (CAGR) of 7.7% • Growth Driver: Rising Incidence Of Penile Cancer Fuels Expansion Of The Penile Cancer Market • Market Trend: Advanced Cancer Trials Transform The Penile Cancer Treatment Market Presence • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Penile Cancer Market?

Penile cancer refers to the development of malignant (cancerous) cells in the tissues of the male reproductive organ responsible for urination and sexual function. Penile cancer can originate in various parts of the penis, including the glans (head), foreskin, shaft, or other areas. The main types of penile cancer are squamous cell cancer of penis, aden carcinoma of penis, melanoma of the penis, basal cell cancer of penis and sarcoma of penis. Squamous cell carcinoma (SCC) refers to a type of cancer that originates from the squamous cells, which are flat, thin cells lining the surface of the penis. It was treated with various therapies, such as radiation therapy, chemotherapy, biological therapy, and surgery, using biopsy, ultrasound, and imaging tests. These are used for several applications, including hospitals, clinics and others.

What Is The Penile Cancer Market Growth Forecast?

The penile cancer market size is expected to see strong growth in the next few years. It will grow to $37.41 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rising adoption of immunotherapy and biological treatments, increasing use of personalized medicine approaches, expansion of early detection programs, growth of telemedicine and remote monitoring, increasing investment in penile cancer research and awareness. Major trends in the forecast period include increasing use of ai for early diagnosis and risk assessment, growing adoption of genomics-based targeted therapies, integration of cloud and big data for patient management, use of iot-enabled devices for monitoring treatment outcomes, implementation of smart manufacturing in biological therapy production.

Global Penile Cancer Market Segmentation

1) By Type: Squamous Cell Cancer Of Penis, Aden Carcinoma Of Penis, Melanoma Of The Penis, Basal Cell Cancer Of Penis, Sarcoma Of Penis 2) By Type Of Therapy: Radiation Therapy, Chemotherapy, Biological Therapy, Surgery 3) By Diagnostic Test: Biopsy, Ultrasound, Imaging Tests 4) By Application: Hospital, Clinics, Other Applications Subsegments: 1) By Squamous Cell Cancer Of Penis: Invasive Squamous Cell Carcinoma, Non-Invasive Squamous Cell Carcinoma 2) By Adenocarcinoma Of Penis: Penile Adenocarcinoma, Mucinous Adenocarcinoma, Non-Mucinous Adenocarcinoma 3) By Melanoma Of The Penis: Superficial Spreading Melanoma, Nodular Melanoma, Acral Lentiginous Melanoma 4) By Basal Cell Cancer Of Penis: Nodular Basal Cell Carcinoma, Superficial Basal Cell Carcinoma, Morpheaform Basal Cell Carcinoma 5) By Sarcoma Of Penis: Kaposi's Sarcoma, Rhabdomyosarcoma

What Are The Drivers Of The Penile Cancer Market?

The increasing incidence of penile cancer is expected to propel the growth of the penile cancer market going forward. Penile cancer refers to the development of malignant (cancerous) cells in the tissues of the penis. An increase in the incidence of penile cancer can potentially lead to a growth in the demand for diagnostic, surgical, and supportive care services, thus impacting the penile cancer market. For instance, in January 2023, according to reports shared by the American Cancer Society Inc., a US-based voluntary health organization, there will be about 2,050 new cases of penile cancer reported and 470 deaths from penile cancer by 2023. Therefore, the increasing incidence of penile cancer is driving the growth of the penile cancer industry. The rise in the geriatric population is expected to propel the growth of the penile cancer market going forward. The geriatric population refers to individuals who are considered elderly or older adults. Penile cancer predominantly affects older men, with the incidence of the disease increasing with age. It was treated with surgery, radiation therapy, and targeted therapy. The rise in the geriatric population increases the chances of penile infection. For instance, in February 2025, according to the World Health Organization, a Switzerland -based specialized agency of the United Nations, reported that the number of people aged 60 and older worldwide is projected to increase from 1.1 in 2023 to 1.4 billion by 2030. Therefore, the rise in the geriatric population is driving the growth of the penile cancer industry.

Key Players In The Global Penile Cancer Market

Major companies operating in the penile cancer market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Bristol‑Myers Squibb Company, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Novartis AG, F Hoffmann‑La Roche Ltd, Johnson & Johnson, AbbVie Inc., GlaxoSmithKline plc, BeiGene Ltd., Iovance Biotherapeutics Inc, Lisata Therapeutics Inc, Halozyme Therapeutics Inc, Sotio Biotech, Sanofi S A, Genmab A S, Otsuka Pharmaceutical Co Ltd, Adaptimmune Therapeutics plc, Apceth Biopharma GmbH & Co KG

Global Penile Cancer Market Trends and Insights

Major companies operating in the penile cancer market are focusing on innovative solutions, such as advanced cancer trials, to address unmet medical needs and improve treatment outcomes. Advanced cancer trials involve testing new treatments, therapies, or medications on patients with late-stage cancer to evaluate their safety and effectiveness. For instance, in May 2023, the ECOG-ACRIN Cancer Research Group, a US-based scientific organization, enrolled 100 patients in the InPACT (International Penile Advanced Cancer Trial), which offers hope for men with advanced cancer of the penis. The International Penile Advanced Cancer Trial (InPACT) is a research initiative focused on studying advanced stages of penile cancer, aiming to improve treatment outcomes and quality of life for affected individuals. It assesses novel therapies, surgical approaches, and interventions for patients with advanced penile cancer, seeking advancements in medical care and understanding of this rare but serious condition.

Regional Outlook

North America was the largest region in the penile cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Penile Cancer Market?

The penile cancer market includes revenues earned by entities by providing services such as screening and diagnosis, treatment options, psychosocial support, multidisciplinary treatment, surgical interventions, and radiation therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Penile Cancer Market Report 2026?

The penile cancer market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the penile cancer industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.